These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32879329)

  • 41. Profiling of orthosteric and allosteric group-III metabotropic glutamate receptor ligands on various G protein-coupled receptors with Tag-lite
    Belhocine A; Veglianese P; Hounsou C; Dupuis E; Acher F; Durroux T; Goudet C; Pin JP
    Neuropharmacology; 2018 Sep; 140():233-245. PubMed ID: 30099051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein-Coupled Receptor.
    De Min A; Matera C; Bock A; Holze J; Kloeckner J; Muth M; Traenkle C; De Amici M; Kenakin T; Holzgrabe U; Dallanoce C; Kostenis E; Mohr K; Schrage R
    Mol Pharmacol; 2017 Apr; 91(4):348-356. PubMed ID: 28167741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allosteric modulation and functional selectivity of G protein-coupled receptors.
    Gao ZG; Jacobson KA
    Drug Discov Today Technol; 2013; 10(2):e237-43. PubMed ID: 24050274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Scale of Agonism and Allosteric Modulation for Assessment of Selectivity, Bias, and Receptor Mutation.
    Kenakin T
    Mol Pharmacol; 2017 Oct; 92(4):414-424. PubMed ID: 28679508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ligand detection in the allosteric world.
    Kenakin TP
    J Biomol Screen; 2010 Feb; 15(2):119-30. PubMed ID: 20086210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advances in G protein-coupled receptor allostery: from function to structure.
    Christopoulos A
    Mol Pharmacol; 2014 Nov; 86(5):463-78. PubMed ID: 25061106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. G-protein-coupled receptor allosterism: the promise and the problem(s).
    Christopoulos A; May LT; Avlani VA; Sexton PM
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):873-7. PubMed ID: 15494038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allosteric modulation of G protein-coupled receptors.
    May LT; Avlani VA; Sexton PM; Christopoulos A
    Curr Pharm Des; 2004; 10(17):2003-13. PubMed ID: 15279541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Approaches for probing allosteric interactions at 7 transmembrane spanning receptors.
    Klein MT; Vinson PN; Niswender CM
    Prog Mol Biol Transl Sci; 2013; 115():1-59. PubMed ID: 23415091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A kinetic view of GPCR allostery and biased agonism.
    Lane JR; May LT; Parton RG; Sexton PM; Christopoulos A
    Nat Chem Biol; 2017 Aug; 13(9):929-937. PubMed ID: 28820879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3.
    Milligan G; Stoddart LA; Smith NJ
    Br J Pharmacol; 2009 Sep; 158(1):146-53. PubMed ID: 19719777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allosteric coupling and biased agonism in G protein-coupled receptors.
    Bock A; Bermudez M
    FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. G protein coupled receptors as allosteric proteins and the role of allosteric modulators.
    Kenakin T
    J Recept Signal Transduct Res; 2010 Oct; 30(5):313-21. PubMed ID: 20858023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu
    Hellyer SD; Albold S; Wang T; Chen ANY; May LT; Leach K; Gregory KJ
    Mol Pharmacol; 2018 May; 93(5):504-514. PubMed ID: 29514854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties.
    Urwyler S; Gjoni T; Koljatić J; Dupuis DS
    Neuropharmacology; 2005 Mar; 48(3):343-53. PubMed ID: 15721166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The function and allosteric control of the human sweet taste receptor.
    Servant G; Kenakin T; Zhang L; Williams M; Servant N
    Adv Pharmacol; 2020; 88():59-82. PubMed ID: 32416872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probe dependence and biased potentiation of metabotropic glutamate receptor 5 is mediated by differential ligand interactions in the common allosteric binding site.
    Hellyer SD; Sengmany K; Keller AN; Christopoulos A; Leach K; Gregory KJ
    Biochem Pharmacol; 2020 Jul; 177():114013. PubMed ID: 32389635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding.
    Gomes I; Ijzerman AP; Ye K; Maillet EL; Devi LA
    Mol Pharmacol; 2011 Jun; 79(6):1044-52. PubMed ID: 21415307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modelling and simulation of biased agonism dynamics at a G protein-coupled receptor.
    Bridge LJ; Mead J; Frattini E; Winfield I; Ladds G
    J Theor Biol; 2018 Apr; 442():44-65. PubMed ID: 29337260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A1 adenosine receptor.
    Guo D; Venhorst SN; Massink A; van Veldhoven JP; Vauquelin G; IJzerman AP; Heitman LH
    Br J Pharmacol; 2014 Dec; 171(23):5295-312. PubMed ID: 25040887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.